We are live on ! Find out more
BBH icon

VanEck Biotech ETF

52 hedge funds and large institutions have $112M invested in VanEck Biotech ETF in 2013 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,300% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 1

212% more call options, than puts

Call options by funds: $6.46M | Put options by funds: $2.07M

33% more funds holding

Funds holding: 3952 (+13)

21% more capital invested

Capital invested by funds: $91.9M → $112M (+$19.7M)

14% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 14

2.1% more ownership

Funds ownership: 21.31%23.41% (+2.1%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
52
Holders Change
+13
Holders Change %
+33.33%
% of All Funds
1.51%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
16
Reduced
14
Closed
1
Calls
$6.46M
Puts
$2.07M
Net Calls
+$4.39M
Net Calls Change
+$1.17M
Name Holding Trade Value Shares
Change
Change in
Stake
BRM
26
Boston Research & Management
Massachusetts
$737K -$62.5K -747 -8%
BPCE
27
Bank Pictet & Cie (Europe)
Germany
$658K +$621K +7,430 New
GJIC
28
Gamble Jones Investment Counsel
California
$531K
NPC
29
National Planning Corporation
California
$502K +$131K +1,569 +39%
BPC
30
Banque Pictet & Cie
Switzerland
$438K +$414K +4,950 New
PTC
31
Private Trust Company
Ohio
$399K
Wells Fargo
32
Wells Fargo
California
$383K +$60.2K +720 +20%
Envestnet Asset Management
33
Envestnet Asset Management
Illinois
$339K +$135K +1,609 +72%
TRCT
34
Tower Research Capital (TRC)
New York
$338K +$319K +3,815 New
CAN
35
Cetera Advisor Networks
California
$323K +$19.7K +236 +7%
First Manhattan
36
First Manhattan
New York
$265K
FAAS
37
First Allied Advisory Services
California
$257K +$247K +2,955 New
CIBC World Market
38
CIBC World Market
Ontario, Canada
$239K +$226K +2,701 New
SC
39
Sumit Capital
New York
$229K +$216K +2,584 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$212K +$201K +2,400 New
PNC Financial Services Group
41
PNC Financial Services Group
Pennsylvania
$211K +$50.2K +600 +34%
MFS
42
MSI Financial Services
Massachusetts
$170K +$23.8K +285 +17%
MCM
43
Manchester Capital Management
Vermont
$158K +$149K +1,780 New
AIG
44
American International Group
New York
$156K +$8.95K +107 +6%
Schroder Investment Management Group
45
Schroder Investment Management Group
United Kingdom
$114K
Deutsche Bank
46
Deutsche Bank
Germany
$74K +$13.4K +160 +24%
KPCM
47
Kings Point Capital Management
New York
$24K
SHWM
48
Smith & Howard Wealth Management
Georgia
$21K
PIM
49
Parasol Investment Management
Illinois
$20K +$18.8K +225 New
PFO
50
Pathstone Family Office
New Jersey
$16K +$15.1K +180 New

BBH Hedge Fund Activity: Q4 2013 in Review

52 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2013, worth a combined $112M — up 21% from $91.9M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new BBH positions and 1 closed out — a net gain of 13 holders — while 16 added to existing stakes and 14 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $6.67M. The largest seller was Factory Mutual Insurance, cutting an estimated $4.18M.

  • 52 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2013, up from 39 in Q3 2013.
  • Funds reported $112M of VanEck Biotech ETF stock for Q4 2013, up 21% quarter-over-quarter.
  • 14 funds opened new VanEck Biotech ETF positions in Q4 2013 and 1 closed out, a net change of +13 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2013 was Susquehanna International Group, an estimated $6.67M added.
  • The largest VanEck Biotech ETF seller in Q4 2013 was Factory Mutual Insurance, an estimated $4.18M sold.

Based on aggregated 13F filings for Q4 2013.